^○Sujan Kabir¹, Golam Mohi², Jian Mei¹, Huyuan Yang¹, Carl Stapinski¹, Hongliang Cai¹, Jason M. Foulks¹, Steven L. Warner¹, Claudia Lebedinsky¹ (1.Sumitomo Dainippon Pharma Oncology, Inc., 2.University of Virginia School of Medicine)

^○Toshiki Yamada¹, Hisashi Tsurumi² (1.Department of Hematology, Gifu Prefectural General Medical Center, 2.Department of Hematology, Matsunami General Hospital)

^○Yuhei Shibata, Takayuki Goto, Naoki Hayase, Yoshikazu Ikoma, Junichi Kitagawa, Yasuhito Nannya, Seishi Ogawa, Senji Kasahara (Department of Hematology, Gifu Municipal Hospital)

^○Hiroyuki Takahashi¹, Takaaki Takeda¹, Jun Nukui¹, Yuto Hibino¹, Mayumi Tokunaga¹, Taisei Suzuki¹, Hideaki Nakajima², Rika Sakai¹ (1.Department of Hematology and Medical Oncology, Kanagawa Cancer Center, 2.Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine)

^○Chisato Mizutani, Kohei Tada, Masaharu Tashima, Hitomi Kaneko, Kazunori Imada (Department of Hematology, Japanese Red Cross Hospital of Osaka)

^○Shinsuke Mizutani¹, Saeko Ota¹, Yuka Kanayama¹, Ayako Muramatsu¹, Haruya Okamoto¹, Akio Onishi¹, Kentaro Mizuhara¹, Yoko Taminishi¹, Reiko Isa¹, Takahiro Fujino¹, Daichi Nishiyama¹, Yayoi Kimoto¹, Taku Tsukamoto¹, Yuji Shimura¹, Tsutomu Kobayashi¹, Kazuho Shimura², Ryoichi Takahashi³, Hiroto Kaneko², Junya Kuroda¹ (1.Division of Hematology and Oncology, Department of Medicine Kyoto Prefectural University of Medicine, 2.Department of Hematology, Aiseikai Yamashina Hospital, 3.Department of Hematology, Omihachiman Community Medical Center)

^○Yu Yagi¹, Sasaki Yuki², Hayashi Yuudai¹, Mino Mano¹, Ohigashi An¹, Morita Yuka¹, Tamura Taichi¹, Nakamura Shohei¹, Okuya Toshihiro¹, Kageyama Akihiko¹, Kanemasa Yusuke¹, Shimoyama Tatsu¹, Omuro Yasushi¹ (1.Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, 2.Department of Clinical Research, Tokyo Metropolitan Cancer and Infectious Diseases Center)

^○Toshiya Hino¹, Akira Honda¹, Arika Shimura¹, Yosuke Masamoto¹, Mineo Kurokawa^1,2 (1.Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 2.Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital)

^○Soichiro Fujii, Makoto Takeuchi (Department of Hematology, Japanese Red Cross Okayama Hospital)

^○Mano Mino¹, Yuuki Sasaki², Yudai Hayashi¹, An Ohigashi¹, Yuka Morita¹, Taichi Tamura¹, Shouhei Nakamura¹, Toshihiro Okuya¹, Yu Yagi¹, Akihiko Kageyama¹, Yusuke Kanemasa¹, Tatsu Shimoyama¹, Yasushi Omuro¹ (1.Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 2.Data Center, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital)

^○Sayaka Suzuki^1,2, Satoshi Kuwamoto³, Koji Kawamura^1,2, Michiko Matsushita⁴, Yuzuru Hosoda^1,2, Masaya Maegaki¹, Kentaro Hara¹, Rina Hosoda¹, Toru Motokura², Tetsuya Fukuda¹ (1.Department of Hematology, Tottori University Hospital, 2.Division of Clinical Laboratory Medicine, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University, 3.Department of Pathology, Faculty of Medicine, Tottori University,, 4.Department of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University.)